Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-03 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.800 | -0.790 | 0.0100 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
RYTM | Rhythm Pharmaceuticals | 25.98 | 0.48 | 1.88% | 1.3B |
You can purchase shares of Rhythm Pharmaceuticals (NASDAQ: RYTM) through any online brokerage.
Other companies in Rhythm Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), 4D Molecular Therapeutics (NASDAQ:FDMT) and Protagonist Therapeutics (NASDAQ:PTGX).
The latest price target for Rhythm Pharmaceuticals (NASDAQ: RYTM) was reported by Morgan Stanley on 2021-03-02. The analyst firm set a price target for 57.00 expecting RYTM to rise to within 12 months (a possible 119.40% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Rhythm Pharmaceuticals (NASDAQ: RYTM) is $25.98 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Rhythm Pharmaceuticals.
There is no upcoming split for Rhythm Pharmaceuticals.